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The purpose of this study was to assess the potential for
rapid acquisition computed axial tomography (Imatron
C-IOO) to quantify regional myocardial perfusion. Myo-
cardial and left ventricular cavity contrast clearance curves
were constructed after injecting nonioniccontrast (I mllkg
over 2 to 3 seconds) into the inferior vena cava of six
anesthetized, closed chest dogs (n = 14). Independent
myocardial perfusion measurements were obtained by
coincident injection of radiolabeled microspheres into
the left atrium during control , intermediate and maxi-
mal myocardial vasodilation with adenosine (0.5 to 1.0
mg/kg per min. intravenously, respectively). At each
flow state. 40 serial short-axis scans (If the left ventricle
were taken near end-diastole at the midpapillary muscle
level. Contrast clearance curves were generated and ana-
lyzed from the left ventricular cavity and posterior pap-
illary muscle regions after excluding contrast recircu-
lation and minimizing partial volume effects. The area
under the curve (gamma variate function ) was deter-
mined for a region of interest placed within the left ven-
tricular cavity.
Characteristics of contrast clearance data from the
posterior papillary muscle region that were evaluated
included the peak myocardial opacification. area under
Th e ability to noninvasivel y assess regional myocardial per -
fusion and flow reserve would sig nificantly aid in the di-
agnosis and treatment of pat ient s with heart disease . There
are at present five general methods that can potentially be
employed to evaluate myocardi al perfu sion in man . They
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the contrast clearance curve and a contrast clearance
time defined by the full width/half maximal extent of the
clearance curve. Myocardial perfusion (microspheres)
ran ged from 35 to 450 mi/IOO g per min (mean 167 ±
(25). Two flow algorithms derived from characteristics
of the contrast clearance curves showed a good corre-
lation with regional myocardial flow determined by mi-
crospheres: I) the ratio of the peak myocardial opaci-
fication from baseline to the area under the left ventricular
cavity curve (r = 0.7, P < 0.001. SEE = 44.4 ml/min ).
and 2) the ratio of the left ventricular cavity to posterior
papillary muscle curve areas divided by the full widthlbalf
maximal contrast transit time in the region of the pos-
terior papillary muscle (r = 0.82 , P <- 0.001, SEE =
52.2 ml/IOO g per min ). The form of these two flow
algorithms was deri ved from classical indicator dilution
theory.
In conclusion, indices der ived from these data cor-
related well with regional myocardial perfusion in the
posteri or papillary muscle region of the dog as assessed
by microspheres. This approach offers promise for the
quantitation of regional myocardial perfusion and myo-
cardial flow reserve in patients.
(J Am Coli Cardiol 1987;9:59-69)
are: inert gas clea rance techn iques ( 1-3). thermodilut ion
techn iques (4). Doppl er techn iques (5.6 ). positron em ission
(7-9) and co ntrast-de nsity clearance techniques (digi tal sub-
traction angiography ( 10.11) and two-dimension al echo-
cardiography [12 .13)) . The ex isting methods as appl ied to
man requ ire cardiac catheterization (inert gas techn ique ,
digital subtraction angiography . ec hoca rdiography. therm al
dilution . Doppler catheter). cardiac surgery (suction mounted
Doppler ) or the generation of posit ron emitting rad io-
nucl ides .
An easi ly applied. widel y avai lable and relatively non -
invas ive means of measuring regional myocard ial per fusion
in the majorit y of patients would repre sent a major devel-
opmental step forward in the ca re of pat ients with coronary
heart di sease . Computed tomograph y can be used to serially
0135-1097/871$),50
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image cardiac structures after bolus intravenous injection of
iodinated contrast (14). A recently introduced rapid acqui-
sition computed axial tomography scanner developed by
Boyd (15) allows for multilevel scanning during consecutive
cardiac cycles. Potentially regional myocardial perfusion
may be assessed by externally recording contrast (computed
tomographic density) clearance curves within an operator-
defined region of interest placed in the myocardium. Herein
we report a preliminary study in six dogs evaluating the
potential for such ultrafast computed tomography to quantify
regional myocardial perfusion.
Theoretical Considerations
Assumptions of indicator dilution theory. The theory
underlying the application of rapid acquisition computed
tomography to measurements of regional myocardial per-
fusion requires that the device act as an external videoden-
sitometer. The indicator in this instance is iodinated contrast
and it is assumed that certain fundamental assumptions of
indicator dilution theory are not violated. These assumptions
are as follows:
I. Complete mixing of indicator: This assumption is gen-
erally true because the intravenously injected contrast
material will have traversed at least two cardiac mixing
chambers (right and left ventricular cavities) before en-
tering the coronary ostia.
2. The volume of indicator injected is negligible: In prac-
tice, injections consist of between 0.5 and 1.0 mllkg of
contrast. This amount of contrast can be assumed to
contribute negligibly to the total circulating blood vol-
ume.
3. The indicator does not perturb hemodynamic equilib-
rium: It is well established that intravascular adminis-
tration of conventional ionic contrast agents such as a
meglumine sodium diatrizoate (Renografin-76) is asso-
ciated with a variety of hemodynamic perturbations that
can occur within Seconds after injection. Thus, myo-
cardial perfusion could be dynamically changing during
the first pass of contrast medium violating the above
assumption. However, studies using the newer nonionic
contrast agents have demonstrated little or no changes
in coronary flow or systemic hemodynamics after intra-
venous administration (16,17). Figure 1 demonstrates a
study performed in our laboratory in the dog evaluating
left ventricular pressure, mean aortic pressure, coronary
blood flow velocity (as assessed using Doppler veloci-
metry) and first derivative of left ventricular pressure
(dP/dt) after bolus intravenous administration of an ionic
contrast agent (meglumine sodium diatrizoate, Reno-
grafin-76) and a nonionic contrast agent (lohexol, Ster-
ling-Winthrop Laboratories). Significant changes in
baseline hemodynamics are seen within a few seconds
after injection of Renografin-76, but not after bolus
administration of Iohexol. Thus, baseline systemic
hemodynamics do not appreciably change after injection
of nonionic contrast agents. The studies reported herein
used Iohexol as the blood flow indicator.
4. There is no extravascular loss of indicator: It is well
known that iodinated contrast medium has both an in-
travascular and extravascular volume of distribution.
However several studies have shown that during the first
pass of contrast agent it remains primarily intravascular
(18,19). It is during this first pass of contrast material
through the systemic circulation that regional indicator
contrast clearance curves would be employed in the at-
Figure 1. Simultaneous left ventric-
ular (LY) pressure, mean aortic blood
pressure (BP), relative coronaryblood
flow velocity (CBFY) (leftanteriorde-
scending Dopplersignal) and first de-
rivative of leftventricular pressure dP/dt
in a dog after a bolus (I mllkg over
2.5 seconds) inferiorvena cava injec-
tion of meglumine sodium diatrizoate
(Renografin-76) and lohexol (t =
time of injection).
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Mathematical algorithms. Based on the previous as-
sumptions, one can propose mathematical algorithms that
may be applied toward calculations of regional myocardial
perfusion using rapid acquisition computed tomography.
The general form of the expression is given in the equation
Here, myocardial fl ow (Fr) (absolute), is equal to the product
of the fraction of total contrast (indicator) mass entering the
myocardial region of interest (f) and the total left ventricular
forward fl ow (FLY) (identical to cardiac output). This equa-
tion was originally proposed by Sapirstein (21) and is the
basis for the use of radioJabeled microspheres to calculate
tissue fl ow.
The variable. f. can be derived from classical indicator
dilution theory (see Appendix) to have the form
f = C, Vtlm, (2)
where C, = a " characteristic" CT number for the myo-
cardial (tissue) contrast clearance curve (to be subsequently
defined). VI' = the vascular volume of contrast within the
region of interest and m = the total mass of indicator (io-
dine) injected intravenously (assuming there is no contrast
lost in the pulmonary circulation) (note here that the variable
Er. defined in the Appendix. is assumed to be unity for the
purposes of this preliminary study). Although VI' is not
known, a priori, the myocardial (tissue) fl ow per unit volume
can be then given as follows (combining equations III and
12)):
tempt to quantitate regional myocardial perfusion by rapid
acquisition computed tomography.
5. The indicator is administered as a hollis: Ideally, intra-
venous contrast administration cannot be accomplished
as a true bolus (step) input function; however, the con-
trast agent must be given sufficiently rapidly such that
the rate of injection does not alter the subsequent char-
acteristics of the output function (arterial contrast clear-
ance curves). Burbank et al. (20) have shown that char-
acteristics of intraaortic digital subtraction contrast
clearance curves (mean transit time, peak opacification)
after intravenous contrast administration are not altered,
provided the injection time is less than one-half the aortic
contrast mean transit time. Contrast injection times of 3
seconds or less in the central venous circulation in the
dog appear to satisfy this requirement in the studies to
be presented (see Discussion).
6. The contrast density can be accurately measured: This
requires that the tomographic scanner be able to accu-
rately determine relative changes in computed tomo-
graphic number within a defined cardiac region of in-
terest during acquisition of sequential stop action
tomograms after bolus contrast administration.
Methods
Tomographic scanner. A rapid acquisition tomographic
scanner was employed for our studies (Irnatron C- IOO) .
Magnetic deflection of an electron beam results in rapid
sweeping across one of four semicircular (210°) tungsten
targets that surround the subject producing individual to-
mographic scans in 50 ms. Up to 80 scans can be taken in
sequence during a single contrast injection. Slice thickness
of each tomogram is 0.8 ern, Electrocardiographic triggering
at a designated time during each cardiac cycle allows for
stop action scans obtained as the iodinated contrast agent
traverses the left ventricular cavity and myocardium after
bolus intravenous injection. Available off-line image anal-
ysis software allows for characterization of arterial and myo-
cardial indicator (contrast) dilution curves within any op-
erator defined region of interest.
Animal preparation. Each of the six closed chest dogs
(weight 15 to 30 kg) were anesthetized with a combination
of intravenous droperidol and fentanyl (Innovar-Vet, O. I
mllkg) and intravenous sodium pentobarbital (10 mg/kg),
The dogs were mechanically ventilated with room air by
way of a cuffed endotracheal tube. Anesthesia was main-
tained by supplemental doses of sodium pentobarbital and
Innovar-Vet as needed. An angiographic catheter (6 F) was
placed in the inferior vena cava by way of a femoral vein.
This catheter was used for injection of contrast material and
as venous access. Two 18 gauge catheters were placed in
the femoral arteries for continuous monitoring of arterial
blood pressure and for radiolabeled microsphere sampling.
In each dog a balloon tipped (7.5F) end-hole catheter was
positioned in the left atrium by way of a right internal jugular
transeptal approach as previously described (23).
Data acquisition. Short-axis (tranverse) scans were ob-
tained at the mid- to low papillary muscle level in each dog.
This was accomplished by placing the dog right side down
and producing a shallow degree of leftward slew of the
imaging table (nominally 15°) with respect to the body's
long axis and scanner gantry. One or two localization scans
(with and without contrast) were taken to determine the
appropriate scan level in each dog at the mid-left ventricle.
After a 20 second period of mechanical hyperventilation (45
resp/min) the animal' s respiration was suspended at peak
inspiration. and differentially labeled 15 f.L microspheres
Here, substitution has been made using the classical Stewart-
Hamilton relation. FLY = m/ALV (22) (see Appendix). As-
suming a myocardial density of 1.05 g/cc, the myocardial
flow (cc/min)/IOOg of tissue can be calculated as follows:
60 seconds 100 g
F,N, = C,/A 1 y x X --"'--
mi n 1.05 glee
= 5.800C,/AL y (ec/lOO g per min) (4)
( I)
(3)
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Myocardial bloodfiow was calculated using the formula:
MBF = C'" x RBF/C', where MBF = myocardial blood
flow in cc/100 g per min: C'" = counts per gram of myo-
cardium, RBF = reference blood flow from the aortic sam-
ple and C' = total counts in the reference blood. The blood
flow, sample rate and geometric reference number for each
segment was punched on paper tape. Subsequent computer
analysis was performed to determine regional myocardial
perfusion per 100 g of tissue.
Analysis of contrast clearance curves. Individual to-
mographic images were displayed on a black and white
monitor with the brightness of each volume element (voxel,
1.02 X 1.02 x 8 mm) assumed linearly proportional to
the local X-ray attenuation coefficient of each tissue section
examined. For each individual tomographic scan left ven-
tricular endocardial and epicardial borders were identified.
Border identification was accomplished by identifying the
left ventricular myocardial edge as that computed tomo-
graphic density corresponding to halfway between that of
obvious left ventricular myocardium and adjacent cardiac
structures (anterior chest wall, lung, left ventricular cavity
and right ventricular cavity). This method of border iden-
tification has been previously shown to allow for highly
accurate determinations of left ventricular mass in dogs us-
ing rapid acquisition computed tomography (24). Employ-
ing a track ball guided cursor, computer generated regions
of interest were placed in the left ventricular cavity and left
ventricular myocardium well within its defined borders. By
previously identifying the borders of the left ventricular
myocardium, spurious results due to inapparent placement
of the myocardial region of interest within a bordering car-
diac or thoracic structure were minimized (therefore, in
effect significantly reducing data analysis errors secondary
to partial volume phenomenon).
For each selected region of interest within the myocar-
dium (approximately 7 x 7 pixels) and left ventricular
cavity (10 x 10 pixels) at each separate myocardial per-
fusion state in all dogs, contrast density versus time data
were generated employing available C-100 software. From
these, data on-line gamma-variate function curves (25) were
fit to each corresponding data set after excluding points
representing obvious contrast recirculation.
Specific flow algorithms. Two values for the variable,
Cr, are suggested by derivations found in the Appendix. In
particular, one form defines C, = CPH (peak myocardial
contrast opacification). The other form is C, = Arltr (ratio
of area under the myocardial tissue contrast clearance curve
to the "full width/half maximal" contrast clearance time).
Calculation of myocardial flow per unit volume by this
method then takes on two forms (equation [3]).
were injected into the left atrium over approximately 30
seconds and flushed with 10 ml of warmed saline. Simul-
taneous with the injection of the microspheres, 1 mllkg of
Iohexol (350 mgllcc) was injected as a bolus into the inferior
vena cava over 2 to 3 seconds. Forty serial, near end-
diastolic, electrocardiographic-triggered tomograms were
taken in the following sequence: 5 scans taken before con-
trast injection followed by a scan per cardiac cycle for the
next 15 cycles and then 1 every other cardiac cycle for the
next 20. Therefore, total scan acquisition occurred over 60
consecutive cardiac cycles. Aortic pressure, electrocardio-
gram and timing of each individual scan were recorded
continuously during each experiment.
Scans were performed at control values of myocardial
perfusion as well as at intermediate and maximal coronary
vasodilation produced by the administration of intravenous
adenosine (0.5 and 1.0 mg/kg per min, respectively).
Differently labeled microspheres were injected during
each separate myocardial perfusion state (scandium-46,
strontium-85, cerium-I43, neodymium-95, tin-II3, gado-
linium-I53). Vials containing microspheres were agitated
for 3 minutes by use of a vortex mixer before injection.
Approximately 5 to 8 X 106 microspheres were injected
for each perfusion measurement. Reference blood samples
were drawn at 7.0 mllmin from both femoral arteries be-
ginning 20 seconds before each injection and continuing for
3 minutes after completion of injections. Reference blood
samples were collected from timed withdrawals from the
femoral artery catheters.
Dataanalysis: microsphere measurements of regional
myocardial perfusion. After each experiment, the heart
was excised and the free wall of the right ventricle, atria,
great vessels, valves and surface vessels were removed. The
left ventricle was then divided into 7 to 10 slices, 0.8 to
1.0 cm thick, parallel to the atrioventricular groove and
perpendicular to the long axis of the left ventricle. Identi-
fication of the left ventricular regions interrogated by the
tomographic scanner for each animal and for each separate
myocardial perfusion state were compared grossly with the
left ventricular slices using intemallandmarks (interventric-
ular septum, high, mid- and low papillary muscles, apex).
This was done to insure determinations of microsphere con-
tent at about the same left ventricular (myocardial) regions
selected as regions of interest during evaluation of the to-
mographic scans. Following identification of several left
ventricular areas (for example, anterior free wall, interven-
tricular septum, anterior and posterior papillary muscle re-
gions) the transmural myocardial samples were weighed to
the nearest milligram, placed in glass tubes and put in a 3
inch (7.62 em) well type iodine gamma counter. Reference
blood samples were then divided into aliquots and counted
separately. Appropriate energy windows were employed and
isotope separation was accomplished with standard tech-
niques.
FrNr = A/ALV
Note here it is not assumed CPH*tr = At.
(A)
(B)
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Figure 2. Schematic illustrations of left ventricular
cavity and myocardial contrast clearance curves as as-
sessed byrapid acquisition computed tomography (CT)
after bolus intravenous administration ofiodinated con-
trast agent. Characteristics of each curve evaluated are
as identified (see text for full explanation). A = area
under curve (gamma-variate); CPH = peak opacifica-
tion; t = empiric transit time (full widthlhalf maximum).
These formulations (A and B) have also been suggested
in previous studies. Formulation A was used by Mullani
and Gould (9) for regional myocardial perfusion using ru-
bidium-82. Formulation B was implied by derivations made
by Axel (26) for studies of regional cerebral blood flow
using computed tomography.
Individual analysis ofthe myocardial and left ventricular
cavity time-density data for myocardial flow calculations
was accomplished according to the schematic presented in
Figure 2. In particular, analysis of the left ventricular cavity
time density (contrast clearance) data is shown schemati-
cally in the left panel and consists of determination of the
peak conttast opacification (peak computed tomographic
density) and area under the curve (A) after excluding the
presence of contrast recirculation.
Specific characteristics of the myocardial contrast clear-
ance curve were evaluated as shown schematically in the
right panel of Figure 2. These characteristics were the peak
myocardial opacification (CPH ) , area under the contrast
clearance curve (At)(gamma variatecurve fit after excluding
recirculation) and a derived contrast clearance time defined
as the full width/half maximal clearance time (tf ) (see Ap-
pendix).
Statistical analysis. Correlations between regional myo-
cardial perfusion as assessed by the radiolabeled micro-
sphere method and from indices derived from the computed
tomographic data were analyzed using linear (least squares)
regression. Hemodynamic data are presented as mean ±
SO.
Results
For the purposes of these preliminary studies data anal-
ysis was confined to the region of the posterior papillary
muscle. Quantitative analysis of contrast density data from
the anterior, lateral and septal myocardial walls was not
performed because of the presence of variable and random
image reconstruction artifacts (see Discussion). These ar-
tifacts precluded estimation of myocardial perfusion using
ultrafast computed tomography in those regions. The pos-
terior papillary muscle region was selected for data analysis
in this preliminary study because the data from this area
were relatively free of obvious contrast clearance curve ar-
tifacts (see Discussion).
Qualitative observations of contrast clearance curves
within the posterior papillary muscle region. Figure 3
shows contrast density versus time data in the posterior
SIMUlTANEOUS l VC/PMM
(SECONDS)
g:Left VentricularCavity (LVC)Posterior Papillary
Muscle (PPM)
120
Figure 3. Top, Schematic illustra-
tion of a cardiac: short-axis tomogram
in thedog at the low papillary muscle
level. Left panel, Simultaneous con-
trast density (computed tomographic
ICT] density) versus time data within
theleftventricular cavity andposterior
papillary muscle regions after a bolus
right atrial injection of Iohexol. Right
panel, Posterior papillary muscle con-
trast density versus time data from a
dog at a high regional myocardial per-
fusion state (340 cc/lOO g permin) and
a low rest myocardial perfusion state
(40 ce/lOO g per min).
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Figure S. Comparison of myocardial perfusion in the posterior
papillary muscle region of the dog as assessed by radiolabeled
microspheres and rapid acquisition computed axial tomography
(RACAT) usingflowalgorithmB (A,IALv*tr) (see text for details).
A, = area undermyocardial contrast clearancecurve; tr = empiric
myocardial contrast mean transit time; other abbreviations as in
Figure 4.
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fusion values as assessed by micro spheres varied from 30
to 450 mllIOO g per min (mean 167 ± 125). The area under
the left ventricular cavity contrast density curve and the
peak myocardial computed tomographic number above
baseline , as well as the area under the myocardial contrast
clearance curve and full width /half maximal tissue clearance
time were evaluated individually for each myocardial per-
fusion state in each dog. Linear regression was employed
to define the best correlation possible between indices de-
rived from the myocardial/left ventricular cavity contrast
curves and regional radiolabeled microsphere content in the
posterior papillary muscle region of each dog.
Absolute calculations of myocardial perfusion per 100 g
of tissue using algorithm A yielded a significant correlation
with radiolabeled microspheres (r = 0.7 and SEE = 44.4
cc/100 g per min, p < 0.001) (Fig . 4). Using algorithm B
the correlation was significantly improved (r = 0.82 and
SEE = 52.2 cc/100 g per min, p < 0.(01) (Fig. 5).
papillary muscle and left ventricular cavity of one dog after
bolus intravenous administration of iodinated contrast. The
left panel shows simultaneous contrast density data from
the left ventricular cavity and posterior papillary muscle
region s. From these data one can make two specific obser-
vation s: I) The peak myocardial opacification is signifi-
cantly less than that seen in the left ventricular cavity. 2)
The time of peak myocardial opacification is delayed beyond
that of left ventricular cavity peak opacification. In addition,
the presence of contrast recirculation can be seen, partic-
ularly in the left ventricular cavity curve.
High and low myocardial perfusion states. The right
panel of Figure 3 shows computed tomographic density
versus time data in the posterior papillary muscle region of
the same dog during two separate myocardial perfusion states.
Myocardial regions of interest were sized such that they
evaluated contrast clearance data across the entire trans-
mural segment. Radiolabeled regional microsphere blood
flow was determined in those same areas. These curves
repre sent myocardial perfusion at two significantly different
myocardial perfusion states: high myocardial perfusion (340
ccllOO g per min) and a low resting state (40 ccllOO g per
min). From these data one can make two specific qualitative
observations: I) The peak myocardial opacification com-
puted tomographic density is significantly greater during the
higher myocardial perfusion state . 2) The time for the con-
trast to wash in and wash out of the defined myocardial
region of intere st is prolonged in the lower myocardial per-
fusion state.
Quantitative measurements of myocardial perfusion
in the posterior papillary muscle region. Mean aortic
pressure and heart rate during control states averaged 70 ±
10 mm Hg and 65 ± 15 beats/min, respectively. A total
of 14 scan/microsphere pairs were judged technically ade-
quate for detailed data analysis. Regional myocardial per-
Figure 4. Comparison of myocardial perfusion in Ihe posterior
papillary muscle region of the dog as assessed by radiolabeled
microspheres (abscissa) and rapid acquisition computed axial to-
mography (RACAT) (ordinate) using fl ow algorithm A (CPH/A)
(see text for details). ALV = area under left ventricular cavity
contrast clearance curve; CPH = peak myocardial opacification.
400
(C", / A,, )
vs . MicrosPheres
300
Regional
Myocardial
Perfusion by 200
RACAT
(ec/minl
100 gms) 100
100 200 300 400
Regional Mycardial Perfusion by Microspheres
(cc/min/100 gms)
Discussion
Two conclusions can be derived from this preliminary
study on the capability of ultrafast computed tomography
for noninvasive quantitation of regional myocardial perfu-
sion. First, high quality contrast density data can be gen-
erated by rapid acquisition computed tomography in the left
ventricular cavity and posterior left ventricular myocardium
after bolus inferior vena cava administration of iodinated
contrast. Second, specific mathematical algorithms derived
from characteristics of the left ventricular and myocardial
contrast clearance curves appear to correlate well with re-
gional myocardial perfusion in the posterior papillary mus-
cle region of the dog as determined by radiolabeled micro-
spheres. This disproves the null hypothesis with regard to
tissue flow calculations made using ultrafast computed to-
JACC Vol. 9, No. I
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mography. As with the introduction of any new technique,
it is imperative to consider sources of experimental errors.
It is also appropriate to consider approaches toward im-
provement in the correlations, specific flow measurement
algorithms and future research directions.
Sources of Experimental Measurement Error
and Potential Methods to Improve Data Acquisition
and Analysis
1. Heterogeneity of contrast clearance curves. Re-
gional blood flow within the normal myocardium (and thus
contrast clearance curves) should be relatively homogeneous
in character (27). However, a significant degree of heter-
ogeneity of the contrast clearance curves was observed de-
pending on whether the identically sized myocardial region
of interest was placed in the anterior, lateral, ventricular
septal or posterior papillary muscle regions. An example of
such contrast clearance curve heterogeneity is illustrated in
Figure 6 which demonstrates simultaneous time-computed
tomographic density data (mean ± SO) in the anterior,
lateral, posterior and septal myocardial regions in one dog.
The most significant data heterogeneity and statistical noise
appear in the anterior myocardial wall especially at a time
coincident with the appearance of contrast in the left ven-
tricular cavity, These artifacts were generally not seen in
the posterior myocardial wall contrast clearance data and
this was the reason why the preliminary analysis reported
here was confined to that myocardial region.
The heterogeneity of recorded contrast clearance curves
is artifactual. There are two major image reconstruction
artifacts well known to computed tomography that result in
distortion of the X-ray density within a region of interest:
beam hardening and Compton (photon) scatter (28), Beam
hardening involves the attenuation of lower X-ray energies
as the polychromatic X-ray beam passes through structures
of varying X-ray density. Regional computed tomographic
densities may therefore be highly variable depending on the
X-ray density of surrounding structures. In particular the
anterior myocardial wall is adjacent to the sternum and one
might expect excessive imaging artifacts to be present in
this position.
Another major source of imaging artifact is scattered
radiation (both at the detector and within the subject). This
occurs when photons reach the detectors from regions of
the tomogram not directly within the line of site of the
original X-ray/detector pair. This imaging artifact produces
changes in relative computed tomographic density similar
to that seen from the beam hardening phenomenon, In other
words, calculated computed tomographic density can de-
crease if the X-ray density of surrounding structures is dy-
namically increasing (for example, contrast bolus entering
and leaving the left or right ventricular cavities). It is not
clear which of these two factors is the most important as a
source for artifactual data, but preliminary studies suggest
that photon scatter is the more significant physical phenom-
enon contributing to the artifacts displayed on Figure 6. The
fact that imaging artifacts were not readily obvious in the
posterior myocardium in the data presented does not imply
that computed tomographic densities in this region were not
artifactually altered.
2. Motion artifact. Apparent cardiac motion occurring
during scanning is secondary to both respiration as well as
scan acquisition at different phases of the cardiac cycle. Our
Figure 6. Simultaneous computed to-
mographic contrast density (CT number) CT
versus time data in a dog within four sep- DENSITY
arate myocardial regions (anterior wall, lat-
eral wall, posterior wall, interventricular
septum). Each data point represents a mean
CT number ± SO.
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data were recorded during suspended respiration after a hy-
perventilatory period. Intrinsic cardiac motion was mini-
mized because of rapid scan acquisition (50 ms) during a
relatively quiescent period of the cardiac cycle (near end-
diastole). The present C-100 software allows the operator
to define a region of interest in the myocardium for each
individual scan. This approach allows for correction of mi-
nor degrees of region of interest misregistration as a con-
sequence of scanning either at slightly different times during
the cardiac cycle or during respiratory variations. The re-
sulting contrast clearance curves represent a record of frame
by frame computed tomographicdensity withineach of these
regions of interest. In this study the contribution of cardiac
motion to imaging artifacts was determined to be minimal.
3. Partial volume effect. Because of the finite thickness
of each individual scan (0.8 ern), contrast density near the
endocardial and epicardial edges may be erroneous if the
shape of the edge changes dramatically within the slice (that
is. through the "voxel "). Thus a region of interest near the
endocardial surface may contain myocardium as well as
contrast filled cavity. This "partial volume" effect can sub-
stantially complicate the data analysis. In our preliminary
studies we attempted to minimize partial volume problems
by employing a previously validated method of cardiac edge
detection and the use of cardiac short-axis (transverse) tom-
ograms at the midventricular level. Because of small changes
in the curvature of the cardiac edge through the finite slice
thickness of midventricular short-axis tornograrns. cardiac
partial volume effects were minimized. Scans nearly per-
pendicular to the long axis of the left ventricle (transverse
slices) can readily be obtained in patients.
4. Standardization of data acquisition and analysis.
Of paramount importance is the standardization of input
function techniques and data analysis. One such concern
relates to the placement. size and shape of the region of
interest used to generate the contrast clearance curves. Our
preliminary studies demonstrated little dependence of re-
gional contrast clearance curves on region of interest shape
but did reveal that larger regions of interest resulted in an
expected decrease in density variation (statistical noise) be-
tween scans (increased signal to noise ratio). Reduction of
image reconstruction artifacts through hardware/software
modifications may enable the choice of smaller regions of
interest in subsequent studies.
For these preliminary studies we chose to administer the
contrast agent as a relatively tight bolus into the inferior
vena cava of each dog; however, the optimal amount, rate
and site of contrast injection remain to be established. In
this series of studies mean contrast transit times (first mo-
ment of the gamma-variate curve fit) for the left ventricular
cavity were on the order of 5 to 6 seconds which is ap-
proximately two times the contrast injection rate (see as-
sumption 5 under Theoretical Considerations).
Data analysis algorithms. This study has shown that
specificalgorithms evaluating characteristics of the left ven-
tricular cavity and posterior papillary muscle contrast clear-
ance curves significantly correlate with regional myocardial
perfusion as assessed by microspheres. The denominator of
each of theseexpressions is the area under the left ventricular
cavity contrast clearance curve and is consistent with the-
oretical considerations detailed in the Appendix. This curve
area. in effect, normalizes for the input function of contrast
entering the coronary ostium and subsequently to the op-
erator-definedregions of interest placed in the myocardium.
Use of the peak myocardial opacification (peak computed
tomographic density) for the numerator of the blood flow
expression (formulation A) can be derived from classical
indicator dilution theory and has been used by Mullani and
Gould (9) for evaluation of regional myocardial perfusion
employing a handheld beta probe and rubidium-82. How-
ever, in their study it was assumed that all rubidium entered
the myocardiumbefore it washed out. No such assumptions
were made or implied in the present study. It can further
be shown that the numerator of the expression shown in
Figure 5 (the ratio of the area under the myocardial contrast
clearance curve to the contrast full width/half maximal transit
time), for a curve of the shape of an indicator dilution curve,
is nearly identical to the peak opacification (29). In effect.
therefore. expressions A and B theoretically should be iden-
tical; however, as can be seen from the data they, in fact,
did not result in the same numerical values. This probably
occurred because imaging artifacts produced spurious de-
creases in the actual peak myocardial opacification. Thus.
employing peak height (peak computed tomographic density
above baseline) as the numerator for the flow algorithm may
result in a substantially lower numerically calculated re-
gional myocardial perfusion. However. a small spurious
decrease in the overall magnitude of the peak myocardial
opacification (as may occur with a combination of beam-
hardening and Compton scatter) may result in little change
in the area under the curve as defined using the gamma
variate approach. Minor variations in absolute peak opaci-
fication values do not substantially alter the "full width/half
maximal" contrast transit time.
A remaining question relates to why regression slopes of
only 0.4 to 0.6 were found in this study. Statistics were not
improved using curvilinear regression relations. One ob-
vious possibility is that inapparent imaging artifacts were
present in the posterior myocardium as was observed in
other myocardial areas. This explanation seems the most
reasonable. Although variable contrast extravasation could
be present. reported data do not suggest this occurs signif-
icantly during the first pass of contrast through vascular
channels. The tissue contrast clearance curves reflect the
characteristics of contrast movement through all vascular
segments within the operator-definedregionof interest. Sub-
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This analogy should hold true for the "myocardial" region, f.
Thus,
The question remaining: what is the value for f? For a contrast
(indicator) clearance curve as observed in the left ventricular cavity
(LV) the area (ALV) under the curve can be approximated as (22):
(2)
(rn'k)
(m-ru'k) :::::; (m)
AORTA
Figure Al
CORONARIES
LEFT VENTRICLE
(rn)
the fraction of total indicator mass delivered to the system is much
less than the remaining mass of indicator in the aorta, that is,
(m - K*m) = m].
For any region in the coronary "tissue" designated as f, the
flow, Fr, (absolute) is directly proportional to the fraction of total
mass of indicator delivered to that region. This is the principle of
Sapirstein (21) and the basis for the microsphere technique. Thus,
in the main coronary arteries a, b or c the flow (absolute) is also
given as:
stantial variations in calculated data at low rest myocardial
flow states may reflect substantialheterogeneity in vascular
contrast transit times that subsequently become more ho-
mogenous after administration of a vascular dilator (aden-
osine) and recruitment of additional vascular channels.
Finally, the variable, E, (see Appendix), which relates
to the full width/halfmaximal contrast clearance time to the
mean (contrast) transit time, was assumed to be unity for
the purposes of the preliminary study; E, can be estimated
directly from the gamma variate curve fits and varied be-
tween 1.05and 1.6 for the data presentedhere. A true bolus-
like left ventricular input function would yield a value of
E, of precisely 1.0 (22). Practically, E, is a variable that
may depend on the site and method of contrast injection as
well as individual hemodynamic variables (for example,
pulmonary/systemic resistance, minimal coronary resist-
ance). Further studies are necessary to fully characterizeEf •
The theoretical and empiric observations noted herein
provide a framework for future studies and extension of
quantitation of myocardial perfusion by ultrafast computed
tomography to all myocardial regions.
Cenclusions, This preliminary study has demonstrated
that regional myocardial perfusion in the posterior papillary
muscle of the dog (microspheres) correlates with indices
derivedfrom myocardial/left ventricularcavity co~trast den-
sity versus time curves measured by rapid acquisition com-
puted tomography over a broad range of myocardial per-
fusion values. Although the preliminary theoretical and
experimental studies are encouraging, they have raised a
number of questions related to technical, theoretical and
practical limitations related to the applicationof this method
to quantitation of regional myocardial perfusion in man.
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(3)
Here, CPH = peak indicator concentration and tA = "full width/half
maximal time." The full width/half maximal time is related to the
time spread of the curve.
From classical indicator dilution theory (22) the following equa-
tions are valid:
Appendix
(4)
(5)
(I)
------f-----
CPHI2
t
I • !.
TIME --
Here, VLV is the central blood volume for the LV cavity (volume
of blood passing through the LV cavity during passage of the
Figure A2
---T---------
CONCENTRATION CPH
m
FLv = -,ALV
where FLV = flow (absolute cardiac output), m = mass of indicator
injected and ALV = area under contrast clearance curve in left
ventricular (LV) cavity. For the coronary arteries/left ventricular
cavity system consider Figure A1. Here, K = a +b +c (the total
mass of indicator delivered to the coronary system) and rn-a, m-b
or m*c represent the mass of indicator delivered to each of the
three major coronary branches, individually. The value of K is
small and K*rn ~ m [which for the coronary arteries states that
From classic indicator dilution theory (22):
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